focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 19.50 (0.00%)
Open: 17.30
High: 0.00
Low: 0.00
Prev. Close: 17.30
CPIC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement relating to election and appointment

29 Feb 2024 14:09

RNS Number : 0201F
China Pacific Insurance Grp Co. Ltd
29 February 2024
 

29 February 2024

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

Election of Directors and Shareholder Representative Supervisors, Appointment of Chairman and Vice Chairman of The Board of Directors, President and the Members of the Special Committees of the 10th Session of the Board of Directors

Reference is made to the announcement on the poll results of the extraordinary general meeting (the "EGM") of China Pacific Insurance (Group) Co., Ltd. (the "Company") dated 29 February 2024.

ELECTION OF DIRECTORS OF THE 10TH SESSION OF THE BOARD OF DIRECTORS

Through the votes of the shareholders of the Company at the EGM, the election and re-election of all the director candidates of the 10th session of the board of directors of the Company (the "Board of Directors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of each of Mr. FU Fan, Mr. HUANG Dinan, Mr. WANG Tayu, Mr. CHEN Ran, Mr. ZHOU Donghui, Ms. LU Qiaoling, Mr. John Robert DACEY, Ms. LIU Xiaodan, Ms. LAM Tyng Yih, Elizabeth, Ms. LO Yuen Man, Elaine, Mr. CHIN Hung I David and Mr. JIANG Xuping as a director of the 10th session of the Board of Directors took effect on the date of the EGM. The appointment qualification of Mr. ZHAO Yonggang is still subject to the approval by the National Administration of Financial Regulation (the "NAFR").

The biographical details of the above directors were set out in the notice of the Company dated 5 February 2024.

The term of office of Mr. WU Junhao, being a director of the 9th session of the Board of Directors, has expired. The Company would like to thank Mr. WU Junhao for his contributions to the Company made during his period of service.

ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISORS OF THE 10TH SESSION OF THE BOARD OF SUPERVISORS

Through the votes of shareholders of the Company at the EGM, the election and re-election of all the shareholder representative supervisor candidates of the 10th session of the board of supervisors of the Company (the "Board of Supervisors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of Mr. ZHU Yonghong as a shareholder representative supervisor of the 10th session of the Board of Supervisors took effect on the date of the EGM. The appointment of Mr. YUE Lin is still subject to the approval by the NAFR.

The biographical details of the above supervisors were set out in the notice of the Company dated 5 February 2024.

The term of office of Mr. LU Ning, being a shareholder representative supervisor of the 9th session of the Board of Supervisors, has expired. The Company would like to thank Mr. LU Ning for his contributions to the Company made during his period of service.

Until the completion of the election of the new session of the Board of Supervisors, the ninth session of the Board of Supervisors is still required to perform its duties in accordance with relevant laws and regulations as well as the provisions of the Articles of Association.

APPOINTMENT OF CHAIRMAN, VICE CHAIRMAN OF THE BOARD OF DIRECTORS AND PRESIDENT

The Company is pleased to announce that the first meeting of the 10th session of the Board of Directors was held on 29 February 2024. At the meeting, Mr. FU Fan was elected as the Chairman of the Board of Directors, Mr. HUANG Dinan was elected as the Vice Chairman of the Board of Directors, and Mr. ZHAO Yonggang was appointed as President.

APPOINTMENT OF THE MEMBERS OF THE SPECIAL COMMITTEES OF THE 10TH SESSION OF THE BOARD OF DIRECTORS

The Board of Directors herby announces that the Audit Committee has been renamed to Audit and Related Party Transaction Control Committee and Risk Management and Related Party Transaction Control Committee has been renamed to Risk Management Committee.

The 10th session of the Board of Directors has five committees, namely the Strategic and Investment Decision-Making & ESG Committee, the Audit and Related Party Transaction Control Committee, the Nomination and Remuneration Committee, the Risk Management Committee and the Technological Innovation and Consumer Rights Protection Committee. The composition of each committee is as follows:

Strategic and Investment Decision-Making & ESG Committee

Chairman: FU Fan (Executive Director)

Other members: CHIN Hung I David (Independent Non-executive Director)

HUANG Dinan (Non-executive Director)

LU Qiaoling (Non-executive Director)

John Robert DACEY (Non-executive Director)

Audit and Related Party Transaction Control Committee

Chairman: LAM Tyng Yih, Elizabeth (Independent Non-executive Director)

Other members: LO Yuen Man, Elaine (Independent Non-executive Director)

ZHOU Donghui (Non-executive Director)

JIANG Xuping (Independent Non-executive Director)

Nomination and Remuneration Committee

Chairman: LIU Xiaodan (Independent Non-executive Director)

Other members: WANG Tayu (Non-executive Director)

CHIN Hung I David (Independent Non-executive Director)

JIANG Xuping (Independent Non-executive Director)

Risk Management Committee

Chairman: ZHAO Yonggang (Executive Director)

Other members: WANG Tayu (Non-executive Director)

LAM Tyng Yih, Elizabeth (Independent Non-executive Director)

LO Yuen Man, Elaine (Independent Non-executive Director)

Technological Innovation and Consumer Rights Protection Committee

Chairman: JIANG Xuping (Independent Non-executive Director)

Other members: CHEN Ran (Non-executive Director)

ZHOU Donghui (Non-executive Director)

ZHAO Yonggang (Executive Director)

 

 

 

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALANAEPLEFA
Date   Source Headline
16th May 202210:21 amRNSAnnouncement relating to Premium Income
28th Apr 20224:21 pmRNSPublication of Summaries of Solvency Reports
28th Apr 20224:18 pmRNS2022 First Quarter Report
28th Apr 20224:01 pmRNSNotice of 2021 AGM
25th Apr 20227:00 amRNS2021 Sustainability Report
14th Apr 202211:59 amRNSAnnouncement relating to Premium Income
28th Mar 20227:00 amRNSProposed amendments to the AoA
28th Mar 20227:00 amRNSPublication of Summaries of Solvency Reports
28th Mar 20227:00 amRNSPublication of 2021 Annual Results Presentation
28th Mar 20227:00 amRNS2021 Annual Report
17th Mar 202212:26 pmRNSConvening of 2021 Annual Results Presentation
10th Mar 20229:26 amRNSAnnouncement relating to Premium Income
15th Feb 20229:21 amRNSAnnouncement relating to Premium Income
19th Jan 202210:44 amRNSPDMR Shareholding
19th Jan 202210:35 amRNSDirector/PDMR Shareholding
19th Jan 202210:32 amRNSAnnouncement relating to Premium Income
14th Jan 202210:59 amRNSDirector/PDMR Shareholding
14th Jan 202210:55 amRNSDirector/PDMR Shareholding
14th Jan 202210:54 amRNSDirector/PDMR Shareholding
17th Dec 20211:27 pmRNSPDMR Shareholding
13th Dec 20219:25 amRNSAnnouncement relating to Premium Income
2nd Dec 20217:00 amRNSPDMR Shareholding
24th Nov 20212:06 pmRNSAnnouncement
12th Nov 20219:37 amRNSCompletion of Change of Registered Capital
12th Nov 20219:34 amRNSAnnouncement relating to Premium Income
29th Oct 202111:15 amRNSProposed Change of Auditors
29th Oct 202111:01 amRNSPublication of Summaries of Solvency Reports
29th Oct 202110:52 amRNS2021 Third Quarter Report
15th Oct 20219:31 amRNSAnnouncement relating to Premium Income
24th Sep 20219:34 amRNSApproval of Articles of Association by CBIRC
16th Sep 202110:00 amRNSAnnouncement relating to Premium Income
1st Sep 20217:00 amRNSPublication of 2021 Interim Results Presentation
1st Sep 20217:00 amRNSPublication of Summaries of Solvency Reports
1st Sep 20217:00 amRNS2021 Interim Report
20th Aug 202111:16 amRNSConvening of 2021 Interim Results Presentation
13th Aug 20219:42 amRNSAnnouncement relating to Premium Income
14th Jul 20219:54 amRNSAnnouncement relating to Premium Income
11th Jun 20219:58 amRNSAnnouncement relating to Premium Income
10th Jun 202110:30 amRNSPDMR Shareholding
4th Jun 202110:20 amRNSChairman of a Subsidiary
3rd Jun 20217:00 amRNSPDMR Shareholding
1st Jun 20217:00 amRNS2020 ESG Report
28th May 20211:31 pmRNSResult of AGM
28th May 202112:54 pmRNSResignation of Vice President
28th May 202112:48 pmRNSAnnouncement re Approval of Appt Qualification
24th May 202110:19 amRNSChange of Venue of the 2020 Annual General Meeting
21st May 202110:15 amRNSAnnouncement regarding GDRs in public hands
11th May 202110:00 amRNSAnnouncement relating to Premium Income
28th Apr 202112:46 pmRNS2021 First Quarter Report
28th Apr 202112:45 pmRNSPublication of Summaries of Solvency Reports

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.